Drug Profile
OP 2507
Alternative Names: ONO 2507Latest Information Update: 04 Oct 2000
Price :
$50
*
At a glance
- Originator Dainippon Pharmaceutical; Ono Pharmaceutical
- Class Anti-ischaemics; Hepatoprotectants; Prostaglandins; Small molecules
- Mechanism of Action Epoprostenol agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cerebrovascular disorders; Liver disorders; Reperfusion injury